COMPANY

EPIEN Medical, Inc. (EMI) is a privately held biomedical company headquartered in St. Paul, Minnesota, USA. The Company is focused on the global health challenges of restoring impaired skin (the bodies largest organ), including both epidermal and dermal layers. This is accomplished through a groundbreaking debridement technology based around a proprietary chemical desiccation process. Our technology platform is called Desiccation Shock Debridement Technology (“DSD”). This proprietary debridement technology is based on a cellular and a molecular process. The products are intended for use by healthcare professionals in the management of oral disease, acute and chronic wounds and burns as well veterinary care. EMI continues to explore multiple disease states that would benefit from its novel molecular and regenerative technology.